How Are New Combination Drugs Registered In South Korea?

In South Korea, new combination drugs are registered through the Ministry of Food and Drug Safety (MFDS). Applicants must provide data demonstrating the safety, efficacy, and rationale for combining the ingredients. Clinical trials or literature reviews are required to prove that the combination offers therapeutic benefits beyond individual components, ensuring effective patient treatment.

Leave a Reply

You must be logged in to post a comment.